DUBLIN--(BUSINESS WIRE)--
Dublin - Research and Markets (http://www.researchandmarkets.com/research/7m2ls7/european_molecular) has announced the addition of Frost & Sullivan's new report "European Molecular Diagnostics Markets" to their offering.
This Frost & Sullivan research service titled European Molecular Diagnostics Markets provides a comprehensive analysis of key challenges, drivers, and restraints as well as recent venue forecasts. It also examines major trends and initiatives in the molecular diagnostics market. The research covers oncology, genetic diseases, infectious diseases and pharmacogenomics segments.
Market Overview
Automation to Play Important Role in Expansion of Molecular Diagnostics Markets
The potential for enhanced clinical efficiency and reduced costs is fuelling the interest of healthcare stakeholders in personalised and preventive medicine. Molecular diagnostics is a vital tool to support this trend. Available molecular diagnostics technologies can detect diseases at very early stages and help monitor the efficacy of therapies being used in disease treatment. Technology advances, paralleled by the decreasing cost of automated systems, will boost market prospects, notes the analyst of this research. Automation, in particular, will play an increasingly important role in market expansion.
Many molecular diagnostic methods were historically based on steps of manual pipetting. Automated devices are nowadays replacing them and offer numerous advantages. These include faster turn-around time (TAT), manipulation of smaller volumes of liquids as well as more accurate and quantifiable results, compared to manual methods. Automation is currently of interest mostly among large diagnostic laboratories, but it is expected that, over time, automated systems will also be available at smaller laboratories, remarks the analyst. In small and medium-sized laboratories, if automation is implemented at all, it is likely to be based on single function automated devices rather than fully automated, comprehensive systems. However, automation of molecular diagnostics is still considered to be insufficient. This is especially the case in sample preparation and nucleic acid extraction, where the majority of work is performed manually. This leads to prolonged TAT, which is a challenge, especially when immediate results are required.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market segments in this research:
- Oncology
Go here to see the original:
Research and Markets: European Molecular Diagnostics Markets
Recommendation and review posted by G. Smith
